
    
      The main objective of this study is to find a more effective treatment for itchy, painful or
      unsightly dermatofibromas, that will improve symptoms of itch and/or pain and/or improve the
      appearance of dermatofibromas. A secondary objective of this study is to better understand
      the 1540 nanometer Erbium glass laser and its impact on the skin.

      This is an open-label study where subjects will receive a laser treatment at week 0, and week
      4, and then have 2 additional follow-up visits (no laser treatment at these visits).
      Photographs will be taken at each visit and photographs from pre-treatment and follow-up 1
      (week 8) will rated by blinded reviewers after the study to determine efficacy.
    
  